Related Experiment Video

Updated: Jul 14, 2026

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
12:52

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

Cell cycle-related kinase: a novel candidate oncogene in human glioblastoma

Samuel S M Ng1, Yuen-Ting Cheung, Xiao-Meng An

  • 1Department of Chemistry, Open Laboratory of Chemical Biology, The University of Hong Kong, Pokfulam, Hong Kong, China.

Journal of the National Cancer Institute
|June 15, 2007
PubMed
Abstract

Insights

Cell cycle-related kinase (CCRK) is elevated in glioblastoma multiforme, a deadly brain cancer. Suppressing CCRK inhibits tumor growth by halting cell division, suggesting CCRK is a potential oncogene and therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Glioblastoma multiforme (GBM) has a poor prognosis despite aggressive treatments.
  • Identifying novel genes driving GBM progression is critical for developing new therapies.
  • Cell cycle-related kinase (CCRK) is a potential target due to its homology with cyclin-dependent kinase 7.

Purpose of the Study:

  • To investigate the role of CCRK in glioblastoma multiforme (GBM) carcinogenesis.
  • To analyze CCRK expression levels in patient samples and cell lines.
  • To determine the effect of CCRK knockdown on GBM cell proliferation and tumorigenicity.

Main Methods:

  • Analyzed CCRK mRNA expression in 26 glioma samples and normal brain tissue using RT-PCR.
  • Utilized small-interfering RNAs (siRNAs) and short hairpin RNAs (shRNAs) to suppress CCRK in U-373 MG and U-87 MG cells.
  • Assessed cell proliferation, cell cycle distribution, and CDK2 phosphorylation.
  • Evaluated CCRK's effect on tumor growth in a nude mouse xenograft model.

Main Results:

  • CCRK mRNA was significantly upregulated in 74% of high-grade GBM samples and 80% of glioma cell lines.
  • CCRK suppression via siCCRK inhibited GBM cell proliferation in a time- and dose-dependent manner.
  • CCRK knockdown induced G1- to S-phase cell cycle arrest and reduced CDK2 phosphorylation, significantly suppressing tumor growth in vivo.

Conclusions:

  • CCRK is overexpressed in glioblastoma multiforme.
  • CCRK plays a crucial role in GBM cell proliferation and tumorigenesis.
  • CCRK is a potential oncogene and a promising therapeutic target for glioblastoma multiforme.

More Related Videos

Generation of Microtumors Using 3D Human Biogel Culture System and Patient-derived Glioblastoma Cells for Kinomic Profiling and Drug Response Testing09:24

Generation of Microtumors Using 3D Human Biogel Culture System and Patient-derived Glioblastoma Cells for Kinomic Profiling and Drug Response Testing

Published on: June 9, 2016

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...